Treatment of total hyphema with relatively low-dose tissue plasminogen activator

被引:0
作者
Kim, MH
Koo, TH
Sah, WJ
Chung, SM
机构
[1] Kangnam St Marys Hosp, Dept Ophthalmol, Seoul 137701, South Korea
[2] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea
来源
OPHTHALMIC SURGERY AND LASERS | 1998年 / 29卷 / 09期
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:762 / 766
页数:5
相关论文
共 50 条
[31]   The Successful Use of Low-Dose Recombinant Tissue Plasminogen Activator for Treatment of Intracardiac/Pulmonary Thrombosis During Liver Transplantation [J].
Boone, James D. ;
Sherwani, Saadia S. ;
Herborn, Joshua C. ;
Patel, Kinjal M. ;
De Wolf, Andre M. .
ANESTHESIA AND ANALGESIA, 2011, 112 (02) :319-321
[32]   CORONARY THROMBOLYSIS WITH LOW-DOSE SYNERGISTIC COMBINATIONS OF PROUROKINASE AND RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR [J].
KIRSHENBAUM, JM ;
FLAHERTY, JT ;
BAHR, RD ;
LEVINE, HJ ;
LOSCALZO, J ;
SCHUMACHER, R ;
WAHR, D ;
BRAUNWALD, E .
CIRCULATION, 1990, 82 (04) :537-537
[33]   FIBRINOLYTIC PROFILES IN LOCAL LOW-DOSE THROMBOLYSIS WITH STREPTOKINASE AND RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR [J].
BERRIDGE, DC ;
EARNSHAW, JJ ;
WESTBY, JC ;
MAKIN, GS ;
HOPKINSON, BR .
THROMBOSIS AND HAEMOSTASIS, 1989, 61 (02) :275-278
[34]   Intravenous Thrombolysis With Low-Dose Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Response [J].
Toyoda, Kazunori ;
Koga, Masatoshi ;
Minematsu, Kazuo .
STROKE, 2010, 41 (03) :E165-E165
[35]   Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? [J].
Dong, Yi ;
Cao, Wenjie ;
Cheng, Xin ;
Fang, Kun ;
Wu, Fei ;
Yang, Lumeng ;
Xie, Yanan ;
Dong, Qiang .
STROKE AND VASCULAR NEUROLOGY, 2016, 1 (03) :115-121
[36]   Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion [J].
Hattenrach, Lars-Olof ;
Kuhli-Hattenbeach, Claudia ;
Scharrer, Inge ;
Baatz, Holger .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (05) :700-706
[37]   The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy [J].
Wong, Yi-Sin ;
Sung, Sheng-Feng ;
Wu, Chi-Shun ;
Hsu, Yung-Chu ;
Su, Yu-Hsiang ;
Hung, Ling-Chien ;
Ong, Cheung-Ter .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 :257-263
[38]   Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion [J].
Hattenbach, LO ;
Wellermann, G ;
Steinkamp, GWK ;
Scharrer, I ;
Koch, FHJ ;
Ohrloff, C .
OPHTHALMOLOGICA, 1999, 213 (06) :360-366
[39]   Catheter-Directed Low-Dose Tissue Plasminogen Activator for Treatment of Right Atrial Thrombus Caused by a Central Venous Catheter [J].
Orgeron, Gabriela M. ;
Pollard, Jessica L. ;
Pourmalek, Paria ;
Sloane, Peter J. .
PHARMACOTHERAPY, 2015, 35 (10) :E153-E158
[40]   Low-dose tissue plasminogen activator in the treatment of a massive pulmonary thromboembolism in a colon cancer patient treated with bevacizumab: A case report [J].
Sen, Fatma ;
Karavelioglu, Yusuf ;
Arisoy, Arif .
ONCOLOGY LETTERS, 2014, 8 (06) :2779-2781